Archive for September 14th, 2017

Habib Bank AG Zurich is Not Affiliated with Habib Bank Limited (HBL)

Habib Bank AG Zurich is Not Affiliated with Habib Bank Limited (HBL)

14-Sep-2017 Intellasia | BusinessWire | 11:02 PM

ZURICH–(BUSINESS WIRE)–In light of recent news regarding the New York branch of Habib Bank Limited (HBL), Habib Bank AG Zurich wishes to clarify that it has no [...]
» More

Dow Develops Leaders While Addressing World Challenges

Dow Develops Leaders While Addressing World Challenges

14-Sep-2017 Intellasia | BusinessWire | 10:30 PM

Dow Leadership in Action Program Deploys 43 Employees to Vietnam in Collaboration with Government, NGOs and Academic Partners MIDLAND, Mich.–(BUSINESS WIRE)–This [...]
» More

BASE Jumping Equipment Market – Drivers and Forecasts by Technavio

BASE Jumping Equipment Market – Drivers and Forecasts by Technavio

14-Sep-2017 Intellasia | BusinessWire | 10:03 PM

LONDON–(BUSINESS WIRE)–#BASEjumping–Technavio analysts forecast the global BASE jumping equipment market to grow at a CAGR of almost 5% during the forecast [...]
» More

Global Hydrophilic Coatings Market 2017-2021 With Aculon, Biocoat, Harland Medical Systems, Hydromer & DSM Dominating – Research and Markets

Global Hydrophilic Coatings Market 2017-2021 With Aculon, Biocoat, Harland Medical Systems, Hydromer & DSM Dominating – Research and Markets

14-Sep-2017 Intellasia | BusinessWire | 9:01 PM

DUBLIN–(BUSINESS WIRE)–The “Global Hydrophilic Coatings Market 2017-2021″ report has been added to Research and Markets’ offering. The global [...]
» More

Global Railcar Leasing Market 2017-2021: Rising Global Crude Oil Production Drives the Market – Research and Markets

Global Railcar Leasing Market 2017-2021: Rising Global Crude Oil Production Drives the Market – Research and Markets

14-Sep-2017 Intellasia | BusinessWire | 8:54 PM

DUBLIN–(BUSINESS WIRE)–The “Global Railcar Leasing Market 2017-2021″ report has been added to Research and Markets’ offering. The global railcar [...]
» More

Global Li-Fi Market 2017-2022 – Analysis of Growth, Trends and Progress – Research and Markets

Global Li-Fi Market 2017-2022 – Analysis of Growth, Trends and Progress – Research and Markets

14-Sep-2017 Intellasia | BusinessWire | 8:36 PM

DUBLIN–(BUSINESS WIRE)–The “Global Li-Fi Market – Analysis of Growth, Trends and Progress 2017 – 2022″ report has been added to Research [...]
» More

Wipro joins Automotive Grade Linux to Accelerate Open Source Adoption

Wipro joins Automotive Grade Linux to Accelerate Open Source Adoption

14-Sep-2017 Intellasia | BusinessWire | 8:00 PM

SAN FRANCISCO & BANGALORE, India–(BUSINESS WIRE)–#AGL–Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, [...]
» More

Wipro joins The Linux Foundation, Strengthening Collaboration and Commitment to Open Source Technologies

Wipro joins The Linux Foundation, Strengthening Collaboration and Commitment to Open Source Technologies

14-Sep-2017 Intellasia | BusinessWire | 7:29 PM

EAST BRUNSWICK, N.J. & BANGALORE, India–(BUSINESS WIRE)–#AGL–Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information [...]
» More

Newborn Foundation and Masimo Partnership Reaches 52,000 Babies and 1,000 Health Workers through Newborn Screening Initiative in Support of Every Woman Every Child

Newborn Foundation and Masimo Partnership Reaches 52,000 Babies and 1,000 Health Workers through Newborn Screening Initiative in Support of Every Woman Every Child

14-Sep-2017 Intellasia | BusinessWire | 7:00 PM

BORN Project convenes public health stakeholders to highlight key program successes at three-year mark, reinforcing global call to action to support universal newborn pulse [...]
» More

KalVista Pharmaceuticals Reports Fiscal First Quarter Results

KalVista Pharmaceuticals Reports Fiscal First Quarter Results

14-Sep-2017 Intellasia | BusinessWire | 6:30 PM

– Portfolio of Oral Plasma Kallikrein Inhibitors for Treatment of Hereditary Angioedema Continues to Advance – – Intravitreal Diabetic Macular Edema Candidate KVD001 [...]
» More

Production of High Intensity Sweetener in China – Report 2017 – Research and Markets

Production of High Intensity Sweetener in China – Report 2017 – Research and Markets

14-Sep-2017 Intellasia | BusinessWire | 5:42 PM

DUBLIN–(BUSINESS WIRE)–The “Production of High Intensity Sweetener in China 2014-2016″ report has been added to Research and Markets’ offering. [...]
» More

Poxel to Present Results for Imeglimin Phase 2b Study in Japan for the Treatment of Type 2 Diabetes at the European Association for the Study of Diabetes 53rd Annual Meeting

Poxel to Present Results for Imeglimin Phase 2b Study in Japan for the Treatment of Type 2 Diabetes at the European Association for the Study of Diabetes 53rd Annual Meeting

14-Sep-2017 Intellasia | BusinessWire | 5:35 PM

Lyon, FRANCE–(BUSINESS WIRE)–POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative drugs to [...]
» More

Digitizing Employee Experience at Insular Life, Philippines

Digitizing Employee Experience at Insular Life, Philippines

14-Sep-2017 Intellasia | BusinessWire | 5:00 PM

780+ Employees spread across multiple locations to benefit from Digital HR Transformation at Insular Life MAKATI CITY, Philippines–(BUSINESS [...]
» More

McLaren Technology Group announces Wipro as new official technology partner

McLaren Technology Group announces Wipro as new official technology partner

14-Sep-2017 Intellasia | BusinessWire | 4:00 PM

WOKING, United Kingdom & BANGALORE, India–(BUSINESS WIRE)–#IT–McLaren Technology Group and Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading [...]
» More

Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer

Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer

14-Sep-2017 Intellasia | BusinessWire | 4:00 PM

Enzalutamide is the first androgen receptor-inhibitor to demonstrate a statistically significant improvement in metastasis-free survival (MFS) in this patient population in a [...]
» More